Your browser doesn't support javascript.
loading
Quantitation of macropinocytosis in glioblastoma based on high-content analysis.
Wang, Bo; Yao, Xuan; Dong, Qiang; Wang, Xiao-Fang; Yin, Hang; Li, Qiao; Wang, Xiao-Qing; Liu, Yang; Pan, Ya-Wen; Yuan, Guo-Qiang.
Afiliação
  • Wang B; Key Lab of Neurology of Gansu Province, the Second Hospital of Lanzhou University, Lanzhou 730030, Gansu, China; The Department of Neurosurgery, the Second Hospital of Lanzhou University, Lanzhou 730030, Gansu, China; The Second Medical College of Lanzhou University, Lanzhou,730030, Gansu, China.
  • Yao X; Key Lab of Neurology of Gansu Province, the Second Hospital of Lanzhou University, Lanzhou 730030, Gansu, China; The Department of Neurosurgery, the Second Hospital of Lanzhou University, Lanzhou 730030, Gansu, China; The Second Medical College of Lanzhou University, Lanzhou,730030, Gansu, China.
  • Dong Q; Key Lab of Neurology of Gansu Province, the Second Hospital of Lanzhou University, Lanzhou 730030, Gansu, China; The Department of Neurosurgery, the Second Hospital of Lanzhou University, Lanzhou 730030, Gansu, China.
  • Wang XF; Gansu Pharmaceutical Group Science and Technology Research Institute, Lanzhou 730030, Gansu, China.
  • Yin H; Key Lab of Neurology of Gansu Province, the Second Hospital of Lanzhou University, Lanzhou 730030, Gansu, China; The Department of Neurosurgery, the Second Hospital of Lanzhou University, Lanzhou 730030, Gansu, China.
  • Li Q; Key Lab of Neurology of Gansu Province, the Second Hospital of Lanzhou University, Lanzhou 730030, Gansu, China; The Department of Neurosurgery, the Second Hospital of Lanzhou University, Lanzhou 730030, Gansu, China.
  • Wang XQ; Key Lab of Neurology of Gansu Province, the Second Hospital of Lanzhou University, Lanzhou 730030, Gansu, China; The Department of Neurosurgery, the Second Hospital of Lanzhou University, Lanzhou 730030, Gansu, China.
  • Liu Y; Key Lab of Neurology of Gansu Province, the Second Hospital of Lanzhou University, Lanzhou 730030, Gansu, China; The Department of Neurosurgery, the Second Hospital of Lanzhou University, Lanzhou 730030, Gansu, China.
  • Pan YW; Key Lab of Neurology of Gansu Province, the Second Hospital of Lanzhou University, Lanzhou 730030, Gansu, China; The Department of Neurosurgery, the Second Hospital of Lanzhou University, Lanzhou 730030, Gansu, China; The Second Medical College of Lanzhou University, Lanzhou,730030, Gansu, China. El
  • Yuan GQ; Key Lab of Neurology of Gansu Province, the Second Hospital of Lanzhou University, Lanzhou 730030, Gansu, China; The Department of Neurosurgery, the Second Hospital of Lanzhou University, Lanzhou 730030, Gansu, China; The Second Medical College of Lanzhou University, Lanzhou,730030, Gansu, China. El
J Neurosci Methods ; 397: 109947, 2023 09 01.
Article em En | MEDLINE | ID: mdl-37574078
ABSTRACT

BACKGROUND:

Macropinocytosis is a pathway utilized for the internalization of extracellular fluid, albumin and dissolved molecules. Assessing macropinocytosis has been challenging in the past because the combination of manual acquisition and visual evaluation of images is laborious, making this type of assessment difficult for high-throughput applications. Therefore, there is a need to develop sensitive and specific macropinocytosis evaluation methods.

METHODS:

This paper proposed a quantitative and time-saving method for macropinocytosis detection based on high-content analysis (HCA). Additionally, cell proliferation was evaluated using CCK8 test.

RESULTS:

The term "macropinosome index" was defined to estimate macropinocytosis and allow comparisons between different cell lines and treatments. Furthermore, we demonstrated that macropinocytosis can promote glioblastoma (GBM) cell survival under L-glutamine (L-Gln)-deficient conditions that resemble the tumour microenvironment.

CONCLUSIONS:

HCA represents a novel, nonsubjective and high-throughput assay for macropinocytosis assessment. In addition, L-Gln deprivation increased the macropinosome index in GBM cells, suggesting that this process may be used to design GBM therapies. AVAILABILITY OF DATA AND MATERIALS The datasets supporting the conclusions of this article are included within the article and its supplementary materials.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glioblastoma Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glioblastoma Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article